Pharma QC
Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...
May 26, 2025 | News
Cell Impact Secures Follow-Up Order for Test Tools from Leading Asian Industrial Player
Cell Impact AB (publ) has signed an agreement to deliver test tools to a leading industrial player in Asia. The deal confirms Cell Impact's attractive offe...
May 20, 2025 | News
AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders
-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...
May 19, 2025 | News
Streamlining Biologics QC: How Waters’ Empower-MALS Integration Is Reshaping Analytical Workflows
Waters Corporation is tackling the complexity of biologics quality control with the integration of Multi-Angle Light Scattering (MALS) into its Empower&tr...
May 16, 2025 | Interaction
Dymax Expands TPO-Free Light-Curable Adhesive Line from Singapore to Support Global Compliance and Sustainability Goals
- Dymax, a leading manufacturer of rapid light-curing materials and equipment, responds to market interest in sustainable adhesive solutions and ...
May 14, 2025 | News
Leica Microsystems Launches Visoria Series to Streamline Routine Microscopy Across Life Science and Industry
Leica Microsystems, a leading provider of microscopy and scientific instrumentation, has launched the Visoria series of upright microscopes, to help enhanc...
May 08, 2025 | News
Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time
Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...
May 07, 2025 | News
Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...
May 06, 2025 | News
Australia’s Viral Vector Manufacturing Facility Selects SYSPRO Cloud ERP to Drive Quality and Compliance in Biopharma Manufacturing
Viral Vector Manufacturing Facility Pty Ltd (VVMF) has selected SYSPRO for its Cloud ERP system. VVMF is Australia’s first viral...
April 29, 2025 | News
Primo Biotechnology Secures PIC/S GMP and GDP Certifications, Strengthening Global Position in Nuclear Medicine
Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed inspection by Taiwan Food and Dr...
April 25, 2025 | News
Thermo Fisher Opens Advanced Therapies Collaboration Center in Carlsbad to Accelerate Cell Therapy Development
Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its Advanced Therapies Collaboration Center (ATxCC...
April 18, 2025 | News
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program
Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...
April 16, 2025 | News
Shilpa Pharma’s Raichur Unit-2 in India Passes Second Straight FDA Inspection Without Observations
Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Admin...
April 09, 2025 | News
AGC Biologics Sets New Benchmark in Japan With 5,000 L Single-Use Bioreactors at Yokohama CDMO Site
New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan AGC announced a strategic decision about the large-scale singl...
April 08, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
